PROCEPT BioRobotics CFO sells 373 shares

PROCEPT BioRobotics EVP and CFO Kevin Waters reported a small tax-related sale of 373 PRCT shares and retained over 180,000 shares.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) reported an insider transaction by Kevin Waters, EVP and CFO. On September 9, 2026, he sold 373 shares of common stock at $20.953 per share in an open-market or private transaction pursuant to the company’s sell-to-cover tax withholding process, and continued to hold 180,355 shares directly afterward.

Insider Trade Summary

Net Seller: 373 shares

Net Sell 1 txn

Insider Waters Kevin

Role EVP, CFO

Sold 373 shs ($8K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	373	$20.953	$8K

Holdings After Transaction: Common Stock — 180,355 shares (Direct)

Footnotes (1)

1. F1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Key Figures

Shares sold: 373 shares Sale price per share: $20.953 per share Shares held after transaction: 180,355 shares +1 more

4 metrics

Shares sold 373 shares Common stock sale reported for September 9, 2026

Sale price per share $20.953 per share Price for 373 shares sold on September 9, 2026

Shares held after transaction 180,355 shares Directly owned by Kevin Waters following the reported sale

Sell-to-cover shares 373 shares Sold to cover tax withholding on RSU vesting dated September 5, 2026

Key Terms

sell-to-cover process, Restricted Stock Units, tax withholding obligations

3 terms

sell-to-cover process financial

"pursuant to the Issuer's sell-to-cover process for tax withholding"

Restricted Stock Units financial

"in connection with the vesting of the Restricted Stock Units on"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"for tax withholding obligations in connection with the vesting"

FAQ

What insider transaction did PROCEPT BioRobotics (PRCT) report for Kevin Waters?

Kevin Waters, EVP and CFO of PROCEPT BioRobotics, reported selling 373 shares of common stock on September 9, 2026 in an open-market or private transaction tied to tax withholding.

How many PRCT shares did Kevin Waters sell and at what price?

Kevin Waters sold 373 PRCT shares at a price of $20.953 per share on September 9, 2026, as disclosed in the Form 4 filing.

Why were Kevin Waters’ PRCT shares sold in this Form 4 transaction?

The filing states the shares were sold under the issuer’s sell-to-cover process to satisfy tax withholding obligations related to the vesting of Restricted Stock Units on September 5, 2026.

How many PROCEPT BioRobotics (PRCT) shares does Kevin Waters hold after this transaction?

After the September 9, 2026 sale, Kevin Waters directly held 180,355 shares of PROCEPT BioRobotics common stock, according to the Form 4 disclosure.

Was the Kevin Waters PRCT share sale made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan, and the footnote describes a sell-to-cover tax process; no Rule 10b5-1 trading plan is reported for this transaction.

What is the nature of Kevin Waters’ ownership of the reported PRCT shares?

The Form 4 indicates that the reported holdings of 180,355 PRCT shares following the transaction are held with direct ownership by Kevin Waters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:43 PM Accepted by SEC EDGAR 09/10/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Waters Kevin

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		S(1)		373	D	$20.953	180,355	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)